Sylvie Cayphas

2.9k total citations · 2 hit papers
16 papers, 2.5k citations indexed

About

Sylvie Cayphas is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sylvie Cayphas has authored 16 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sylvie Cayphas's work include Viral Infectious Diseases and Gene Expression in Insects (5 papers), Glycosylation and Glycoproteins Research (4 papers) and T-cell and B-cell Immunology (4 papers). Sylvie Cayphas is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (5 papers), Glycosylation and Glycoproteins Research (4 papers) and T-cell and B-cell Immunology (4 papers). Sylvie Cayphas collaborates with scholars based in Belgium, Australia and United States. Sylvie Cayphas's co-authors include Jacques Van Snick, Anne Vink, Richard J. Simpson, Michael R. Rubira, Catherine Uyttenhove, Jo Van Damme, Alfons Billiau, Pierre G. Coulie, Ghislain Opdenakker and Jean‐Pierre Szikora and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Sylvie Cayphas

16 papers receiving 2.4k citations

Hit Papers

Purification and NH2-terminal amino acid sequence of a T-... 1986 2026 1999 2012 1986 1987 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Cayphas Belgium 14 1.3k 716 653 293 265 16 2.5k
Eitan Yefenof Israel 28 1.2k 0.9× 684 1.0× 684 1.0× 117 0.4× 216 0.8× 114 2.4k
Anne Vink Belgium 23 1.8k 1.4× 612 0.9× 710 1.1× 123 0.4× 269 1.0× 30 3.1k
Andrew J. Hapel Australia 25 1.8k 1.3× 925 1.3× 519 0.8× 177 0.6× 379 1.4× 47 3.1k
Shraga Segal Israel 28 1.7k 1.3× 986 1.4× 769 1.2× 239 0.8× 85 0.3× 90 3.1k
Fujiro Sendo Japan 35 2.1k 1.6× 1.2k 1.7× 499 0.8× 335 1.1× 167 0.6× 144 3.8k
H.‐D. Flad Germany 30 1.5k 1.1× 1.0k 1.4× 685 1.0× 126 0.4× 131 0.5× 78 3.3k
R M Marks United States 13 1.1k 0.8× 862 1.2× 330 0.5× 176 0.6× 117 0.4× 17 2.2k
A Alpert Canada 16 1.9k 1.5× 712 1.0× 550 0.8× 97 0.3× 304 1.1× 17 2.8k
Patricia Tekamp-Olson United States 20 1.2k 0.9× 896 1.3× 632 1.0× 122 0.4× 184 0.7× 25 2.8k
Alf Grandien Sweden 30 1.5k 1.2× 1.1k 1.5× 684 1.0× 107 0.4× 236 0.9× 65 3.0k

Countries citing papers authored by Sylvie Cayphas

Since Specialization
Citations

This map shows the geographic impact of Sylvie Cayphas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Cayphas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Cayphas more than expected).

Fields of papers citing papers by Sylvie Cayphas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Cayphas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Cayphas. The network helps show where Sylvie Cayphas may publish in the future.

Co-authorship network of co-authors of Sylvie Cayphas

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Cayphas. A scholar is included among the top collaborators of Sylvie Cayphas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Cayphas. Sylvie Cayphas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Brando, Clara, Lisa A. Ware, April K. Kathcart, et al.. (2006). Murine Immune Responses to Liver-Stage Antigen 1 Protein FMP011, a Malaria Vaccine Candidate, Delivered with Adjuvant AS01B or AS02A. Infection and Immunity. 75(2). 838–845. 18 indexed citations
2.
Putnak, J. Robert, Beth-Ann Coller, Gérald Voss, et al.. (2005). An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model. Vaccine. 23(35). 4442–4452. 130 indexed citations
3.
Daubersies, Pierre, Alan W. Thomas, Pascal Millet, et al.. (2000). Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nature Medicine. 6(11). 1258–1263. 138 indexed citations
4.
Snick, Jacques Van, et al.. (1988). cDNA cloning of murine interleukin-HP1: homology with human interleukin 6. European Journal of Immunology. 18(2). 193–197. 251 indexed citations
5.
Vink, Anne, Peter Vandenabeele, Catherine Uyttenhove, Sylvie Cayphas, & Jacques Van Snick. (1988). Plasmacytoma growth factor activity of murine granulocyte-macrophage colony-stimulating factor.. The Journal of Immunology. 141(6). 1996–1999. 10 indexed citations
6.
Snick, Jacques Van, Sylvie Cayphas, Anne Vink, et al.. (1987). Purification and NH2-terminal Amino-acid-sequence of a New T-cell Derived Lymphokine With Growth-factor Activity for B-cell Hybridomas. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 6(1). 22 indexed citations
7.
Coulie, Pierre G., Annelies Van Hecke, Julien Vandamme, et al.. (1987). B-cell growth modulating and differentiating activity of recombinant human 26-kd protein (bsf-2, huifn-beta-2, hpgf) and preliminary characterization of its cell-surface receptor. Journal of Interferon Research. 7(6). 700–700. 1 indexed citations
8.
Damme, Jo Van, Sylvie Cayphas, J Van Snick, et al.. (1987). Purification and characterization of human fibroblast‐derived hybridoma growth factor identical to T‐cell‐derived B‐cell stimulatory factor‐2 (interleukin‐6). European Journal of Biochemistry. 168(3). 543–550. 92 indexed citations
9.
Damme, Jo Van, Ghislain Opdenakker, Richard J. Simpson, et al.. (1987). Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.. The Journal of Experimental Medicine. 165(3). 914–919. 598 indexed citations breakdown →
11.
Poupart, P, Peter Vandenabeele, Sylvie Cayphas, et al.. (1987). B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF).. The EMBO Journal. 6(5). 1219–1224. 185 indexed citations
12.
Snick, Jacques Van, Anne Vink, Sylvie Cayphas, & Catherine Uyttenhove. (1987). Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.. The Journal of Experimental Medicine. 165(3). 641–649. 150 indexed citations
13.
Cayphas, Sylvie, et al.. (1987). Identification of an interleukin HP1-like plasmacytoma growth factor produced by L cells in response to viral infection.. The Journal of Immunology. 139(9). 2965–2969. 47 indexed citations
14.
Coulie, Pierre G., Sylvie Cayphas, Anne Vink, Catherine Uyttenhove, & Jacques Van Snick. (1987). Interleukin‐HP1‐related hybridoma and plasmacytoma growth factors induced by lipopolysaccharide in vivo. European Journal of Immunology. 17(8). 1217–1220. 47 indexed citations
15.
Damme, Jo Van, Sylvie Cayphas, Ghislain Opdenakker, Alfons Billiau, & Jacques Van Snick. (1987). Interleukin 1 and poly(rI) · poly(rC) induce production of a hybridoma growth factor by human fibroblasts. European Journal of Immunology. 17(1). 1–7. 158 indexed citations
16.
Snick, Jacques Van, Sylvie Cayphas, Anne Vink, et al.. (1986). Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.. Proceedings of the National Academy of Sciences. 83(24). 9679–9683. 629 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026